ArticlePharmacoEconomics2025

Evaluating the Role and Policy Implications of Using External Evidence in Survival Extrapolations: A Case Study of Axicabtagene Ciloleucel Therapy for Second-Line DLBCL.

Sam Harper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.